The critical 340B program, designed to provide discounted medications to safety-net healthcare organizations, is confronting heightened examination by various stakeholders. Issues revolve concerning alleged diversion https://340bdrugpricingprogram044756.blog5.net/98361742/the-current-340b-initiative-under-examination-what-s-in-jeopardy